Viswanathan Krishnan, Chief Corporate Development and Strategy at Agios Pharmaceuticals ($AGIO), made one open market sale of common shares in the last year, totaling $82,260. His most recent sale occurred on March 5, 2026. Among 11,678 insiders, his sales rank 9,842nd by value, well below the average of $8.6 million across 6.4 transactions per insider. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Viswanadhan Krishnan | Chief Corp Dev & Strategy | M | Restricted stock units | 8100 | $0.00 | 16,200.0000 | 74,665,003 | 33.33% | 0.01% |
| March 5, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Viswanadhan Krishnan | Chief Corp Dev & Strategy | S | Common stock | 2959 | $27.80 | 5,141.0000 | 74,665,003 | 36.53% | 0.00% |
| March 5, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Viswanadhan Krishnan | Chief Corp Dev & Strategy | M | Common stock | 8100 | $0.00 | 8,100.0000 | 74,665,003 | 9999.99% | 0.01% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Viswanadhan Krishnan | Chief Corp Dev & Strategy | A | Stock options (right to buy) | 52000 | $0.00 | 52,000.0000 | 74,665,003 | 9999.99% | 0.07% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Viswanadhan Krishnan | Chief Corp Dev & Strategy | A | Restricted stock units | 14000 | $0.00 | 14,000.0000 | 74,665,003 | 9999.99% | 0.02% |
| Aug. 19, 2025 | CARGO Therapeutics, Inc. | $CRGX | Viswanadhan Krishnan | Not found | D | Stock Option (Right to Buy) | 3173 | $0.00 | 0.0000 | 48,364,311 | 100.00% | 0.01% |
| Aug. 19, 2025 | CARGO Therapeutics, Inc. | $CRGX | Viswanadhan Krishnan | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 48,364,311 | 100.00% | 0.05% |
| June 18, 2025 | CARGO Therapeutics, Inc. | $CRGX | Viswanadhan Krishnan | Not found | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 46,052,368 | 9999.99% | 0.05% |
| March 5, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Viswanadhan Krishnan | Chief Corp Dev & Strategy | A | Stock options (right to buy) | 55374 | $0.00 | 55,374.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 5, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Viswanadhan Krishnan | Chief Corp Dev & Strategy | A | Restricted stock units | 24300 | $0.00 | 24,300.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| June 4, 2024 | CARGO Therapeutics, Inc. | $CRGX | Viswanadhan Krishnan | Not found | A | Stock Option (Right to Buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |